New R Series Defibrillators with EtCO2 and NIBP and Temperature Management Solutions Showcased by ZOLL Medical Corporation at American Heart Association Scientific Sessions

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of medical devices and related software solutions, today announced that the R Series® defibrillators with new monitoring capability added as well as its new intravascular temperature management solutions are being exhibited in Booth #1417 at the American Heart Association Scientific Sessions 2009 November 15-17th at the Orange County Convention Center in Orlando.

MORE ON THIS TOPIC